世界の軟骨無形成症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Achondroplasia Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12020 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、軟骨無形成症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。軟骨無形成症治療の種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・軟骨無形成症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Ascendis Pharma A/S、BioMarin Pharmaceutical Inc、Ribomic Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：RBM-007、TA-46、B-701、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・軟骨無形成症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・軟骨無形成症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・軟骨無形成症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・軟骨無形成症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・軟骨無形成症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Achondroplasia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Achondroplasia Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Achondroplasia Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Achondroplasia Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
RBM-007
TA-46
B-701
Others

Market segment by Application, can be divided into
Hospital
Clinic
Others

Market segment by players, this report covers
Ascendis Pharma A/S
BioMarin Pharmaceutical Inc
Ribomic Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Achondroplasia Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Achondroplasia Treatment, with revenue, gross margin and global market share of Achondroplasia Treatment from 2019 to 2021.
Chapter 3, the Achondroplasia Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Achondroplasia Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Achondroplasia Treatment research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Achondroplasia Treatment
1.2 Classification of Achondroplasia Treatment by Type
1.2.1 Overview: Global Achondroplasia Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Achondroplasia Treatment Revenue Market Share by Type in 2020
1.2.3 RBM-007
1.2.4 TA-46
1.2.5 B-701
1.2.6 Others
1.3 Global Achondroplasia Treatment Market by Application
1.3.1 Overview: Global Achondroplasia Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Achondroplasia Treatment Market Size & Forecast
1.5 Global Achondroplasia Treatment Market Size and Forecast by Region
1.5.1 Global Achondroplasia Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Achondroplasia Treatment Market Size by Region, (2016-2021)
1.5.3 North America Achondroplasia Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Achondroplasia Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Achondroplasia Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Achondroplasia Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Achondroplasia Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Achondroplasia Treatment Market Drivers
1.6.2 Achondroplasia Treatment Market Restraints
1.6.3 Achondroplasia Treatment Trends Analysis
2 Company Profiles
2.1 Ascendis Pharma A/S
2.1.1 Ascendis Pharma A/S Details
2.1.2 Ascendis Pharma A/S Major Business
2.1.3 Ascendis Pharma A/S Achondroplasia Treatment Product and Solutions
2.1.4 Ascendis Pharma A/S Achondroplasia Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Ascendis Pharma A/S Recent Developments and Future Plans
2.2 BioMarin Pharmaceutical Inc
2.2.1 BioMarin Pharmaceutical Inc Details
2.2.2 BioMarin Pharmaceutical Inc Major Business
2.2.3 BioMarin Pharmaceutical Inc Achondroplasia Treatment Product and Solutions
2.2.4 BioMarin Pharmaceutical Inc Achondroplasia Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioMarin Pharmaceutical Inc Recent Developments and Future Plans
2.3 Ribomic Inc
2.3.1 Ribomic Inc Details
2.3.2 Ribomic Inc Major Business
2.3.3 Ribomic Inc Achondroplasia Treatment Product and Solutions
2.3.4 Ribomic Inc Achondroplasia Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ribomic Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Achondroplasia Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Achondroplasia Treatment Players Market Share
3.2.2 Top 10 Achondroplasia Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Achondroplasia Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Achondroplasia Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Achondroplasia Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Achondroplasia Treatment Revenue Market Share by Application (2016-2021)
5.2 Achondroplasia Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Achondroplasia Treatment Revenue by Type (2016-2026)
6.2 North America Achondroplasia Treatment Revenue by Application (2016-2026)
6.3 North America Achondroplasia Treatment Market Size by Country
6.3.1 North America Achondroplasia Treatment Revenue by Country (2016-2026)
6.3.2 United States Achondroplasia Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Achondroplasia Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Achondroplasia Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Achondroplasia Treatment Revenue by Type (2016-2026)
7.2 Europe Achondroplasia Treatment Revenue by Application (2016-2026)
7.3 Europe Achondroplasia Treatment Market Size by Country
7.3.1 Europe Achondroplasia Treatment Revenue by Country (2016-2026)
7.3.2 Germany Achondroplasia Treatment Market Size and Forecast (2016-2026)
7.3.3 France Achondroplasia Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Achondroplasia Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Achondroplasia Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Achondroplasia Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Achondroplasia Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Achondroplasia Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Achondroplasia Treatment Market Size by Region
8.3.1 Asia-Pacific Achondroplasia Treatment Revenue by Region (2016-2026)
8.3.2 China Achondroplasia Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Achondroplasia Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Achondroplasia Treatment Market Size and Forecast (2016-2026)
8.3.5 India Achondroplasia Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Achondroplasia Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Achondroplasia Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Achondroplasia Treatment Revenue by Type (2016-2026)
9.2 South America Achondroplasia Treatment Revenue by Application (2016-2026)
9.3 South America Achondroplasia Treatment Market Size by Country
9.3.1 South America Achondroplasia Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Achondroplasia Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Achondroplasia Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Achondroplasia Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Achondroplasia Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Achondroplasia Treatment Market Size by Country
10.3.1 Middle East & Africa Achondroplasia Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Achondroplasia Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Achondroplasia Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Achondroplasia Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Achondroplasia Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Achondroplasia Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Achondroplasia Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Achondroplasia Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Achondroplasia Treatment Revenue Market Share by Region (2021-2026)
Table 6. Ascendis Pharma A/S Corporate Information, Head Office, and Major Competitors
Table 7. Ascendis Pharma A/S Major Business
Table 8. Ascendis Pharma A/S Achondroplasia Treatment Product and Solutions
Table 9. Ascendis Pharma A/S Achondroplasia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioMarin Pharmaceutical Inc Corporate Information, Head Office, and Major Competitors
Table 11. BioMarin Pharmaceutical Inc Major Business
Table 12. BioMarin Pharmaceutical Inc Achondroplasia Treatment Product and Solutions
Table 13. BioMarin Pharmaceutical Inc Achondroplasia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ribomic Inc Corporate Information, Head Office, and Major Competitors
Table 15. Ribomic Inc Major Business
Table 16. Ribomic Inc Achondroplasia Treatment Product and Solutions
Table 17. Ribomic Inc Achondroplasia Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global Achondroplasia Treatment Revenue (USD Million) by Players (2019-2021)
Table 19. Global Achondroplasia Treatment Revenue Share by Players (2019-2021)
Table 20. Breakdown of Achondroplasia Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Achondroplasia Treatment Players Head Office, Products and Services Provided
Table 22. Achondroplasia Treatment Mergers & Acquisitions in the Past Five Years
Table 23. Achondroplasia Treatment New Entrants and Expansion Plans
Table 24. Global Achondroplasia Treatment Revenue (USD Million) by Type (2016-2021)
Table 25. Global Achondroplasia Treatment Revenue Share by Type (2016-2021)
Table 26. Global Achondroplasia Treatment Revenue Forecast by Type (2021-2026)
Table 27. Global Achondroplasia Treatment Revenue by Application (2016-2021)
Table 28. Global Achondroplasia Treatment Revenue Forecast by Application (2021-2026)
Table 29. North America Achondroplasia Treatment Revenue by Type (2016-2021) & (USD Million)
Table 30. North America Achondroplasia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 31. North America Achondroplasia Treatment Revenue by Application (2016-2021) & (USD Million)
Table 32. North America Achondroplasia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 33. North America Achondroplasia Treatment Revenue by Country (2016-2021) & (USD Million)
Table 34. North America Achondroplasia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 35. Europe Achondroplasia Treatment Revenue by Type (2016-2021) & (USD Million)
Table 36. Europe Achondroplasia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 37. Europe Achondroplasia Treatment Revenue by Application (2016-2021) & (USD Million)
Table 38. Europe Achondroplasia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 39. Europe Achondroplasia Treatment Revenue by Country (2016-2021) & (USD Million)
Table 40. Europe Achondroplasia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 41. Asia-Pacific Achondroplasia Treatment Revenue by Type (2016-2021) & (USD Million)
Table 42. Asia-Pacific Achondroplasia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 43. Asia-Pacific Achondroplasia Treatment Revenue by Application (2016-2021) & (USD Million)
Table 44. Asia-Pacific Achondroplasia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 45. Asia-Pacific Achondroplasia Treatment Revenue by Region (2016-2021) & (USD Million)
Table 46. Asia-Pacific Achondroplasia Treatment Revenue by Region (2021-2026) & (USD Million)
Table 47. South America Achondroplasia Treatment Revenue by Type (2016-2021) & (USD Million)
Table 48. South America Achondroplasia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 49. South America Achondroplasia Treatment Revenue by Application (2016-2021) & (USD Million)
Table 50. South America Achondroplasia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 51. South America Achondroplasia Treatment Revenue by Country (2016-2021) & (USD Million)
Table 52. South America Achondroplasia Treatment Revenue by Country (2021-2026) & (USD Million)
Table 53. Middle East & Africa Achondroplasia Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. Middle East & Africa Achondroplasia Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. Middle East & Africa Achondroplasia Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. Middle East & Africa Achondroplasia Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. Middle East & Africa Achondroplasia Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. Middle East & Africa Achondroplasia Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Achondroplasia Treatment Picture
Figure 2. Global Achondroplasia Treatment Revenue Market Share by Type in 2020
Figure 3. RBM-007
Figure 4. TA-46
Figure 5. B-701
Figure 6. Others
Figure 7. Achondroplasia Treatment Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Achondroplasia Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Achondroplasia Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Achondroplasia Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Achondroplasia Treatment Revenue Market Share by Region in 2020
Figure 15. North America Achondroplasia Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Achondroplasia Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Achondroplasia Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Achondroplasia Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Achondroplasia Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Achondroplasia Treatment Market Drivers
Figure 21. Achondroplasia Treatment Market Restraints
Figure 22. Achondroplasia Treatment Market Trends
Figure 23. Ascendis Pharma A/S Recent Developments and Future Plans
Figure 24. BioMarin Pharmaceutical Inc Recent Developments and Future Plans
Figure 25. Ribomic Inc Recent Developments and Future Plans
Figure 26. Global Achondroplasia Treatment Revenue Share by Players in 2020
Figure 27. Achondroplasia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Achondroplasia Treatment Revenue Market Share in 2020
Figure 29. Global Top 10 Players Achondroplasia Treatment Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Achondroplasia Treatment Revenue Share by Type in 2020
Figure 32. Global Achondroplasia Treatment Market Share Forecast by Type (2021-2026)
Figure 33. Global Achondroplasia Treatment Revenue Share by Application in 2020
Figure 34. Global Achondroplasia Treatment Market Share Forecast by Application (2021-2026)
Figure 35. North America Achondroplasia Treatment Sales Market Share by Type (2016-2026)
Figure 36. North America Achondroplasia Treatment Sales Market Share by Application (2016-2026)
Figure 37. North America Achondroplasia Treatment Revenue Market Share by Country (2016-2026)
Figure 38. United States Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Achondroplasia Treatment Sales Market Share by Type (2016-2026)
Figure 42. Europe Achondroplasia Treatment Sales Market Share by Application (2016-2026)
Figure 43. Europe Achondroplasia Treatment Revenue Market Share by Country (2016-2026)
Figure 44. Germany Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Achondroplasia Treatment Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Achondroplasia Treatment Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Achondroplasia Treatment Revenue Market Share by Region (2016-2026)
Figure 52. China Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Achondroplasia Treatment Sales Market Share by Type (2016-2026)
Figure 59. South America Achondroplasia Treatment Sales Market Share by Application (2016-2026)
Figure 60. South America Achondroplasia Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Achondroplasia Treatment Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Achondroplasia Treatment Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Achondroplasia Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Achondroplasia Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source

---